 | Up a level |
Sengayi, M M; Kielkowski, D; Egger, M; Dreosti, L; Bohlius, J (2017). Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study. SAMJ. South African medical journal, 107(10), pp. 871-876. Medical Association of South Africa 10.7196/SAMJ.2017.v107i10.12362
Bohlius, J; Tonia, T; Nüesch, E; Jüni, P; Fey, M F; Egger, M; Bernhard, J (2014). Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. British journal of cancer, 111(1), pp. 33-45. Nature Publishing Group 10.1038/bjc.2014.171
Vehreschild, J J; Böhme, A; Cornely, O A; Kahl, C; Karthaus, M; Kreuzer, K-A; Maschmeyer, G; Mousset, S; Ossendorf, V; Penack, O; Vehreschild, M J G T; Bohlius, J (2014). Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Annals of oncology, 25(9), pp. 1709-1718. Oxford University Press 10.1093/annonc/mdu035
Aapro, M S; Bohlius, J; Cameron, D A; Dal Lago, Lissandra; Donnelly, J Peter; Kearney, N; Lyman, G H; Pettengell, R; Tjan-Heijnen, V C; Walewski, J; Weber, Damien C; Zielinski, C (2011). 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European journal of cancer, 47(1), pp. 8-32. Amsterdam: Elsevier 10.1016/j.ejca.2006.05.002
Bohlius, Julia; Bohlius, J; Schmidlin, K; Costagliola, D; Fätkenheuer, G; May, M; Caro-Murillo, AM; Mocroft, A; Bonnet, F; Clifford, G; Karafoulidou, A; Miro, JM; Lundgren, J; Chene, G; Egger, Matthias (2009). Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral therapy, 14(8), pp. 1065-74. London: International Medical Press 10.3851/IMP1462
